In late-stage CKD, FGF-23 cannot reduce serum phosphate levels, and high FGF-23 concentrations result in left ventricular hypertrophy (LVH), faster CKD progression, and mortality (41). The gene discussed is FGF23; the disease is chronic kidney disease.